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Abstract  
Purpose:  Men with metastatic prostate cancer experience high levels of unmet supportive care needs 
in current healthcare delivery.  We set out to determine the effectiveness of a multimodality 
supportive care (ThriverCare) intervention on the prevalence of unmet supportive care needs for men 
and their partner/caregivers. 
 
Methods: A prospective parallel group, pilot randomised controlled pilot trial in 4 hospitals in 
Scotland.  38 participants with radiologically proven metastatic prostate cancer disease and 10 
partners/caregivers were recruited into the study.  A two arm 1:1 study design compared the usual 
standard of care (SC) approach to SC plus ThriverCare intervention.  The primary outcome was the 
Supportive Care Needs Survey at 3 months of intervention.   
 
Results:   There was no statistical significant difference in the prevalence of unmet supportive care 
needs between the intervention group and the usual SC group at baseline p=0.112, however a 
statistically significant difference was observed at 3 months, indicating that the prevalence of unmet 
supportive care needs were less in the intervention group (1.13, SD 2.5) compared to the usual SC 
(6.17, SD 7.05), p=0.002.   
  
Conclusion:   ThriverCare appears to improve the supportive care experience of men with metastatic 
prostate cancer on hormonal treatment and their partner/caregivers.  Our results accentuate that no 
longer one size of care delivery fits all, care must be responsive and adaptable to meet the individual 
needs of people affected by cancer to thrive. 
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Introduction 
Androgen deprivation therapy (ADT) for metastatic prostate cancer remains the mainstay of treatment 
and has been proven to be effective in controlling disease (Sternberg et al., 2013).  The majority of men 
face a range of physical and psychological problems that can have a profound decrement on quality of 
life and exacerbate the need for supportive care (Cockle-Hearne et al., 2013; King et al., 2015; Paterson 
et al., 2017; Watson et al., 2016).   The treatment specific side effects include hot flushes, osteoporosis,  
fatigue, sexual dysfunction, changes in muscle mass, adiposity, and psychological effects such as, mood 
disturbance, cognitive impairment, difficulties with self-image and masculinities (Fitzpatrick et al., 2014). 
Men affected by metastatic prostate cancer are likely to have a long illness pathway, as well as the 
individual burden to patients and their partner/caregivers with the associated side-effects, and this 
represents a burden on healthcare resources internationally (Carter et al., 2011; Chambers et al., 2018; 
Paterson et al., 2015a; Paterson et al., 2017).   
 
Systematic reviews in the area of unmet supportive care needs in men affected by prostate cancer 
underscore that many can experience on-going and unresolved concerns related to psychological needs, 
managing physical side-effects and a lack of information and support (Chambers et al., 2018; King et al., 
2015; Paterson et al., 2015b).  Moreover, recent evidence acknowledges that current delivery of care is 
failing to provide a person-centred model of supportive care for men and their partner/caregivers 
affected by metastatic prostate cancer (Chambers et al., 2018; Paterson et al., 2017).  National and 
international cancer reforms (McCabe et al., 2013) recognise that men affected by metastatic prostate 
cancer continue to experience a range of complex unmet supportive care needs even in twenty-first 
century healthcare (Carter et al., 2011; Chambers et al., 2018; Paterson et al., 2017).   
 
Supportive care needs are defined as requirements for care arising during treatment and illness to 
manage symptoms and side-effects, enable adaption and coping, optimise understanding and informed 
decision-making, and minimise decrements in functioning (Hui, 2014).  Supportive care is a person-
centred approach to the provision of the necessary services for those living with or affected by cancer to 
meet their informational, spiritual, emotional, social, or physical needs during diagnosis, treatment, 
follow-up and into survivorship (Hui, 2014).  One approach to quality of life evaluation that assesses 
supportive care requirements is needs assessment (Bonevski et al., 2000).  A large body of evidence now 
exists which focusses on the prevalence of unmet supportive care needs in men with prostate cancer 
(Cockle-Hearne et al., 2013; King et al., 2015; Paterson et al., 2017; Primeau et al., 2017; Watson et al., 
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2016), including those with metastases on ADT (Chambers et al., 2018; Paterson et al., 2017; Primeau et 
al., 2017) but little or no evidence has been reported to address possible interventions (McCabe et al., 
2013; Watson et al., 2016).  An innovative pilot multimodal supportive care intervention, called 
ThriverCare (Paterson et al., 2017; Primeau et al., 2017) was designed in the present study and tested 
through a pilot randomised controlled trial.  Thrivercare was informed by the Prostate Cancer Model of 
Consultation as the underpinning theoretical study model (Paterson and Nabi, 2016).  ThriverCare was 
developed to address unmet care need concerns, normalise follow-up treatment experience, and move 
beyond prostate cancer survivorship to cancer thrivership (Weiner et al., 2005).  This pilot randomised 
controlled study aimed to provide supporting evidence for the acceptability and usefulness of the 
ThriverCare intervention for patients and their partners/caregivers affected by metastatic prostate 
cancer compared to the usual standard of care.   
 
Hypothesis 
 
We tested the hypothesis that the ThriverCare intervention would improve 1) supportive care needs, 2) 
psychological outcome, 3) health-related quality of life and 4) self-efficacy in comparison to patients and 
their partner/caregivers receiving the usual standard of care.      
 
Patients and Methods 
Design 
This was a pilot parallel randomised controlled trial conducted according to the Consolidated Standards 
of Reporting Trials (CONSORT) statement guidelines (Schulz et al., 2010). 
 
Participants 
Eligible participants were diagnosed with metastatic prostate cancer on primary androgen deprivation 
therapy (ADT), aged 18 years or over, self-assessed written and verbal English proficiency and, able to 
provide written informed consent.  Radionuclide bone scan/computed tomography (CT) scan or 
magnetic resonance imaging (MRI) confirmed metastatic disease in all the participants.     
 
Exclusion criteria were:  men lacking inclusion criteria, men with dual cancer and those on 
chemotherapy or following relapse of disease.   
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Setting 
The study was undertaken at four hospitals in Scotland from March 2016 to April 2017.  The healthcare 
provision serves a geographical area which consists of a predominantly rural and urban population of 
white ethnicity (405,721) published by the General Register Office for Scotland. The study had NHS 
Ethical approval (16/ES/0024). 
 
Sample Size 
The consortium design of study is shown in Figure 1. As pilot trials do not have the same objectives as a 
main trial, setting the sample size in the same way by utilising a formal power calculation is not 
appropriate (Whitehead et al., 2016). However, we carefully considered the optimum sample size 
justification for the pilot study using guidance from (Billingham et al., 2013; Whitehead et al., 2016).  For 
the main trial designed with 90% power and two-sided 5% significance, we followed a pilot trial sample 
size of 25 per treatment arm for a standardised small effect size (0.2). 
 
Recruitment Process 
Patients were randomly assigned 1:1 to either usual standard of care (SC) or SC plus ThriverCare, see 
Figure 2. Block randomization was used to reduce bias and was generated in a permuted block design 
(Kang et al., 2008).   Participants were randomly assigned and notified of allocation after completion of 
consent and baseline study questionnaires.  As active patient participation is required as part of the 
intervention, a traditional single-blind (i.e. patient level) or double-blind RCT (i.e. patient and 
investigator level) was not deemed feasible in the context of this pilot study. To mitigate the adverse 
effects of blinding bias, the patient information sheets were designed to avoid any reference to the 
‘intervention group’ or ‘control group’.  Patients were only informed that they were randomly allocated 
to one of two different methods of supportive care delivery. 
 
Intervention Group: ThriverCare  
The intervention was developed using the Medical Research Council Framework for complex 
interventions (Craig et al., 2008) and the six steps in quality intervention development (6SQuID) (Wight 
et al., 2015).  The intervention was informed by the Prostate Cancer Model of Consultation (Paterson 
and Nabi, 2016) and  comprised four main components: 1) informational materials, 2) holistic needs 
assessment, 3) individualised self-management care plans, and 4) group-based seminar.  The 
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intervention and associated materials were developed in consultation with multidisciplinary healthcare 
experts involved in prostate cancer and patient’s representatives. 
 
Informational materials 
Participants were provided with a custom-made evidence-based self-management booklet entitled “A 
Prostate Cancer Guide to Thrivership: Men it is time to Thrive” (Supplementary Information).  The 
information booklet covered the following general topics: how to self-care, managing side-effects of 
ADT, nutrition and exercise, relationships and sexual well-being, healthy lifestyle approaches and 
community-based support resources.   
 
Holistic Needs Assessment 
An individualised, nurse-led face-to-face session was conducted across the four hospitals at baseline and 
at three months.  Patients and their partners/caregivers completed the Macmillan’s Holistic Needs 
Assessment (HNA) questionnaire (Doyle and Henry, 2014) ten minutes before the nurse-led session, at 
baseline and at three months.  The HNA questionnaire information was then directly used in the 
consultation to tailor individualised self-management care plans of each patient and their 
partner/caregiver.   The consultation included the discussion of concerns/problems, determining an 
individualised strategy with realistic goals and expectations which could be incorporated into daily life.  
Consultation sessions were concluded by summarising the main issues, making necessary referrals and 
appointments for follow-up including open door access using emails.   
 
Self-management care plans 
Self-management care plans were formatted as written documents provided to the participants at the 
end of the discussion of the HNA in the nurse-led session.  Further copies of the care plans were 
provided to the General Practitioner and filed in the patients’ medical case notes, for quality assurance.   
The Prostate Cancer Model of Consultation (Paterson and Nabi, 2016) and evidence based guidelines for 
nurse-led survivorship care (Paterson et al., 2015a) were used to support the development of shared 
self-management care plans.  The prostate cancer care model (Paterson et al., 2015a; Paterson and 
Nabi, 2016) enabled standardization of evidence-based self-management interventions for precise 
intervention content.    The nurse-led session took place in an out-patient hospital clinic room and lasted 
approximately 30 minutes. 
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Group-based seminar 
The self-management seminar included the following topics:  1) introduction to ADT and potential side-
effects, 2) self-managing side-effects, 3) managing emotions and mind changes, 4) erectile dysfunction 
and relationships, 5) nutrition and exercise, 6) finance and benefits, 7) relaxation and stress 
management, and 8) sign-posting to community-based services and open question session (Figure 3).  
The seminar was led by a senior prostate cancer specialist nurse, physical activity instructor and a 
trained counsellor. 
 
Standard of care/control group: Patients in the control group received the usual standard of care as was 
offered at the hospitals or by their usual clinicians. This involved baseline and three monthly outpatient 
clinic review and does not include any elements of the ThriverCare intervention. 
 
Data collection  
All participants completed the baseline questionnaires on the day of randomization and one further 
questionnaire three months later.  The outcomes measures at baseline and at three months were 
administered by a research assistant not involved in the intervention delivery.  Thirty-three semi-
structured interviews were conducted to explore their experience of supportive care and these data 
have been published elsewhere (Primeau et al., 2017). 
 
Clinical and demographic data 
Demographic and clinical data were collected at the start of the study and included: age, marital status, 
socio-economic (Scottish Index of Multiple Deprivation), employment status, diagnosis, stage of disease, 
prostate specific antigen (PSA), Gleason score, length of time since diagnosis, treatment, and existing co-
morbidities.   Only demographic data was collected from partners/caregivers. 
 
Outcome measures 
All self-report standardized outcome measures were psychometrically validated, responsive, acceptable, 
and have been used in this patient population.   
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Primary outcome 
 
Unmet supportive care needs 
Supportive Care Needs Survey (SCNS-SF34) is a multidimensional self-report questionnaire that evaluates 
34 patient needs that fall under the following five domains: health system and information, 
psychological, physical and daily living, patient care and support, and sexuality.   
 
Secondary outcomes 
 
Self-efficacy  
Self-management Self-Efficacy Scale (SE Scale) provides an assessment of participant's belief and 
confidence to perform their self-management. Self-efficacy is a general term used to describe the belief 
that one can perform a novel or a difficult task, or cope with adversity in various domains of human 
functioning.  
 
Health-related quality of life 
EORTC Quality of Life (QLQ C30) and (PR25) is an integrated measurement system for quality of life in 
cancer participants.  
 
Psychological outcome 
Hospital Anxiety and Depression Scale (HADS) assesses anxiety and depression in non-psychiatric 
patients.  
 
Statistical approach 
All analyses were conducted in SPSS Statistics for Windows version 21.0 (IBM Corp., http://www-
03.ibm.com/software/products/en/spss-statistics). Descriptive statistics were used to summarize 
outcome measures, baseline demographic and clinical characteristics of patients randomized to each 
study arm.  Prior to the analysis, variables were examined for accuracy of data entry, missing values and 
the assumptions of the proposed analysis.   Basic exploratory statistical analysis of indicative findings 
was undertaken to characterise the cohort (Tabachnick and Fidell, 2007).     
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Results 
Of the 73 patients approached to take part in the study, 25 declined participation.   There was a 
statistically significant difference in age between the consented group 75 years (SD 5.9) and non-
consented group 84 years (SD 6.6) p<0.01.  Moreover, we did not observe any statistically significant 
difference in the duration of ADT or time since diagnosis between the two groups p>0.05.  The reasons 
for declining participation included: a lack of time due to being a main carer, dislike of completing 
questionnaires, patients reported that they felt too old, and too much going on with treatment, see 
Figure 1 for Consort diagram. 
 
There were no statistically significant differences in age, employment, Gleason score, number of co-
morbidities, PSA levels between the intervention and standard of care groups, see Table 1.   We 
observed a statistically significant difference in socio-economic (p=0.048) and marital status (p=0.005) 
between the intervention and control groups, but overall the characteristics were well-balanced 
between the two groups.  Time since diagnosis ranged from seven to 56 months. 
 
Primary outcomes 
There was no statistically significant difference in the prevalence of unmet supportive care needs 
between the intervention group and usual SC group at baseline (p=0.112).    A statistically significant 
difference was observed at three months, indicating that the prevalence of unmet supportive care 
needs were less in the intervention group (1.13, SD 2.5) than compared to usual SC (6.17, ± 7.05) 
p=0.002 shown in Figure 4.     The most common unmet supportive care needs identified through 
baseline evaluation included physical symptoms such as fatigue (18.8%), pain (16.7%), fear of the cancer 
spreading (27.1%), uncertainty of the future (29.2%), anxiety of death and dying (18.8%), changes in 
sexual feelings (23.0%), worries and concerns of those closest to you (29.9%), more choice about which 
cancer specialist you would like to see (25.1%), lack of self-management advice (23.0%), unmet 
informational needs (18.8%) and not being informed of test results (22.9%).  
We observed the greatest improvements in the following domains of unmet needs following the 
ThriverCare Intervention at three months (Table 2): physical symptoms (pain 0%, fatigue 7.7%), fear of 
the cancer spreading (7.7%), fear of death and dying (0%), changes in sexual feelings (7.7%), concerns of 
those closest to you (7.7%), more choice about which cancer specialist you see (0%), informational 
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needs (0%), self-management advice (0%), and being informed of test results as soon as is feasible 
(7.7%).  In the control group 205 unmet supportive care needs were reported, and 14 unmet needs in 
the intervention group at three months, noteworthy all the unmet needs in the intervention group were 
scored as “low unmet need” (Table 2).    
Secondary outcomes 
No statistically significant differences were observed between the two groups with regards to, or within 
group score changes on self-efficacy (p=.212), anxiety (p=.101), depression (p=.489) and health related 
quality of life (p=.886) over time (Table 1).   
 
Discussion 
 A significant proportion of men affected by metastatic prostate cancer encounter a broad scope of 
concerns and unmet needs, despite ongoing follow-up care in a range of international counties which 
include Australia, UK, and Canada (Carter et al., 2011; Chambers et al., 2018; Paterson et al., 2017; 
Paterson et al., 2015b).  To our knowledge, this is the first pilot RCT study that compared a multimodal 
supportive care (called ThriverCare) intervention for men and their partners/caregivers and compared 
this to the usual SC.  We hypothesized that the intervention would reduce unmet supportive care needs, 
improve quality of life, reduce anxiety and depression and improve self-efficacy.  Our primary outcome 
was supportive care needs.  We observed a statistically significant main group effect on the prevalence 
of unmet supportive care needs over time, in favour of the ThriverCare intervention.    Integrating the 
evidence-based seminar with the use of Holistic Needs Assessment (HNA) questionnaires in clinical 
practice permitted a tailored, personalised model of care and targeted self-management plans.  Areas of 
supportive care which demonstrated the most improvement included physical symptoms, existential 
concerns (fear of death), choice of which cancer specialist patients see, informational needs and self-
management advice was observed at three months in the intervention group.   Supportive interventions 
which incorporate direct interaction with specialist healthcare professionals and feature individually 
tailored self-management have shown promise in improving patient outcomes elsewhere (Bourke et al., 
2012; Menichetti et al., 2016; Parahoo et al., 2015) but our study is the first to demonstrate a direct 
improvement on the prevalence on unmet supportive care needs in patients with metastatic prostate 
cancer.   
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The intervention did not have any impact on secondary outcomes which included, health-related quality 
of life, anxiety and depression, or self-efficacy over time.  While self-efficacy is a prevalent construct 
used in existing intervention studies, it has inconsistent outcomes (Hofman, 2013). Very few studies 
(Moore et al., 2015)  that have incorporated self-efficacy reported that self-efficacy was not affected by, 
or could explain the intervention effect; similar to the indicative findings in the current study.  
Moreover, our results are in keeping with other supportive care interventions in prostate cancer 
populations, in so far that they also did not demonstrate any changes in health-related quality of life or 
psychological outcome scores (Carmack Taylor et al., 2004; Northouse et al., 2007).  Reasons for no 
statistically significant improvements in these outcomes remains unknown and may need further 
exploratory studies in this area (Primeau et al., 2017). 
 
Patients are increasingly completing standardised patient reported outcome (PRO) questionnaires about 
their symptoms, functioning, well-being, supportive care needs and these PRO data are being used along 
with other clinical information to screen for conditions, monitor progress, and inform patient 
management (Greenhalgh, 2009; Jensen et al., 2014).  Unmet needs of people affected by cancer often 
mediate a poorer quality of life, including greater physical impairment and symptom burden, anxiety 
and depression, and persistent supportive care requirements over time (King et al., 2015).  These 
consequences may be under-recognized and under-treated in oncology practice and this was evident in 
the standard of care group in the present study.  Globally, cancer organizations have published 
supporting recommendations about the pilot and beneficial effects of using PROs in routine clinical 
practice (Abernethy et al., 2010) which underpinned our intervention design.   
 
A number of studies have examined the clinical utility of PRO holistic needs assessment (Bonevski et al., 
2000).  To the best of our knowledge, this is the first pilot RCT to demonstrate an improvement in 
supportive care experience for men affected by metastatic prostate cancer through the use of PRO 
HNA’s in clinical practice, elsewhere studies are currently on-going (Snowden et al., 2015; Stanciu et al., 
2015) .  As a strengthen to our study, we implemented the Prostate Cancer Model of Consultation as 
part of the HNA process (Paterson and Nabi, 2016) which enabled precise standardization of evidence-
based self-management interventions tailored to the individual area of need.  Arguably, the completion 
of HNAs questionnaires in clinical practice alone, are of no benefit or can worsen unmet supportive care 
needs experience, if the clinician does not discuss the unmet needs information documented in the 
consultation, or if the clinician does not have access to precise evidence-based self-management 
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interventions to support or advice the patient appropriately.  A methodological limitation of studies 
elsewhere (Snowden et al., 2015; Stanciu et al., 2015) is that they do not clearly evidence the 
standardization of the intervention content following the completion of the HNA.  Inevitably, this will 
create the opportunity for bias because healthcare professionals vary in experience, knowledge and 
expertise in their ability to develop shared self-management plans to address unmet physical, 
emotional, spiritual, environmental, social, sexual, financial and cultural needs. 
 
A statistically significant difference was observed for marital status and socio-economic status between 
the intervention and control group, which may have affected supportive care, for example, the informal 
care provided by the spouse.  However, this seems unlikely as there was no statistically significant 
difference in the prevalence of unmet supportive care needs between the intervention and control 
group at baseline. Furthermore, there was no statistically significant difference in co-morbidities 
between the two groups, as we recognise multiple health conditions might increase the need and 
provision for supportive care (Holm et al., 2014).  Regardless of the clinical characteristics and time since 
treatment, we observed men with metastatic prostate cancer in the control group continued to 
experience a range of unmet supportive care needs at a follow-up of three months related to, physical 
and psychological problems, fear of cancer spreading, uncertainty of the future, intimacy and sexual 
needs,  and a lack of personalised holistic care, in keeping with the existing evidence base (Carter et al., 
2011; Chambers et al., 2018; King et al., 2015; Paterson et al., 2015b).   
 
One of major findings of this pilot RCT study is that through targeting self-management plans to 
individual needs is one of the most important issues to be considered.  Broad targeting interventions are 
at risk of including men with dissimilar needs, which can affect intervention adherence, study attrition 
and dilute effect. Men’s needs will inevitably differ across the disease, with emotional distress and 
uncertainty of the future being most salient around the time of diagnosis, and symptom problems and 
self-management critical during treatment. We argue, optimising supportive care can be achieved by 
tailoring interventions informed by the ThriverCare to identify individual needs/concerns and address 
each patients requirements individually (Paterson and Nabi, 2016). Individual needs and concerns will 
differ in terms of social support, education, economic status, religion, and ethnicity, and such factors 
should also be taken into account explicitly in targeting and evaluating outcomes (Paterson and Nabi, 
2016).   
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The participation rate into the trial was 67% and similar to other studies in this patient group.  However, 
we observed a statistically significant difference in age between the consent and non-consents groups.  
Typically, clinical trials conducted in the adult population include patients between the ages of 18 and 
65 years, and often elderly patients over >65 years are poorly represented.  Our study highlights some of 
the issues which elderly people with metastatic disease expressed as reasons for non-participation into 
the trial. Time restraints, social circumstances, age and physical activities were important barriers to the 
participation in the present study. 
 
Several limitations are worth noting. First, the study had a small sample size and limited follow-up.  
Second, we lacked information on the actual self-management behaviours performed by participants 
and how this impacted upon their experience of supportive care. Third, this study was biased in favour 
of white participants and as a result, some caution should be taken in the interpretation of these 
findings and requires the study to be replicated with a larger multi-centre sample, and men from 
minority groups to be equally represented.   
 
Conclusion 
This study has demonstrated that the novel ThriverCare intervention for men and their 
partners/caregivers affected by metastatic prostate cancer improves the prevalence of unmet 
supportive care needs over time.  This should inform management and care planning of men with 
metastatic disease on androgen deprivation therapy.  Future studies in other tumour groups should 
carefully consider targeting individuals with significant issues or unmet needs to strive to deliver a 
model of care that is individualised and flexible.  Our results accentuate that no longer one size of care 
delivery fits all, care must be responsive and adaptable to meet the individual needs of people affected 
by cancer to thrive.  
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Excluded: {n=25) 
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Doesn't have t ime due to being main caregiver for 
, wife (n=l), no reason given (n=6), reports feeling too 
old to participate (n=7), doesn' t like questionna ires 
(n=6), feels unwell (n=2), too busy with treatment 
(n=3) 
" 
Randomly assigned (n=48) 
i i 
Allocated to control usual standard of care arm Allocated to Intervention (ThriverCare} arm (n=20): 
(n=29}: Received treatment allocation n=19 
Received treatment allocation n=29 Did not receive treatment allocation (n=l ) deceased 
Did not receive treatment allocation (n=O) 
,, 1, 
Lost to follow-up (n=O) Lost to follow-up (n=O) 
Discontinued (n=l) deceased Discontinued (n=O) 
,, ,, 
Analysis: (n=28} Analysis: (n=19} 
Excluded with reasons (n=O) Excluded with reasons (n=O) 
Figure 1. Flow diagram of the progress through the phases of a parallel randomised trial of two groups (that is, enrolment, intervention 
allocation, fo llow-up, and data analysis) 



Table 1 Clinical and Demographic Characteristics 
 Standard care group (n29) Intervention group (n19) p Value 
Age 77.5 (SD 6.2, min 66 – 93) 
years 
74.9 (SD 8.2, min 60 – 86) years .177 
SIMD* 
Most deprived 
2 
3 
4 
Least Deprived 
 
 
3 (10.3%) 
2 (6.9%) 
6 (20.7%) 
15 (51.7%) 
3 (10.3%) 
 
0 (0%) 
5 (26.3%) 
3 (15.8%) 
5 (26.3%) 
6 (31.6%) 
 
.048* 
Marital status Widowed 11 (37.9%) 
Married 18 (62.1%) 
Single 1 (5.3%) 
Widowed 3 (15.8%) 
Married 15 (78.9%) 
.005* 
Employment status Retired 29 (100%) Retired 19 (100%) .203 
Number of co-morbidities 2.4 (SD 2.8) 2.7 (SD 2.6) .377 
Gleason Score 
6 
7 
8-10 
No pathology 
 
0 (0%) 
2 (6.9%) 
2 (6.9%) 
21 (86.2%) 
 
0 (0%) 
6 (31.6%) 
0 (0%) 
7 (68.4%) 
.202 
PSA diagnosis 
 
PSA Recent 
131.2 (SD 208.2) 
 
12.9 (SD 23.4) 
319.2 (SD 380.6) 
 
20.7 (29.5) 
.052 
 
.363 
Psycho-social constructs 
Anxiety baseline 
Anxiety 3M 
 
Depression baseline 
Depression 3M 
 
Self-efficacy 
Self-efficacy 3M 
 
2.9 (SD 3.4) 
2.1 (SD 1.9) 
 
3.6 (SD 3.6) 
4.1 (SD 4.4) 
 
3.5 SD .8) 
3.6 (SD .6) 
 
2.3 (SD 3.8) 
2.4 (SD 4.6) 
 
3.6 (SD 3.1) 
3.6 (SD 3.6) 
 
3.7 (SD.37) 
3.7 (SD .12) 
 
.686 
.102 
 
.760 
.489 
 
.364 
.212 
Health Related Quality of Life 
Global QoL 
Global QoL 3M 
 
Physical function 
Physical function 3M 
 
Role Function 
Role Function 3M 
 
Emotional Function 
Emotional Function 3M 
 
Cognitive function 
Cognitive function 3M 
 
Social Function 
Social function 3M 
 
Fatigue 
Fatigue 3M 
 
Nausea and vomiting 
Nausea and vomiting 3M 
 
Pain 
Pain 3M 
 
Dyspnoea 
Dyspnoea 3M 
 
73.5 (SD 22.2) 
79.6 (SD 23.9) 
 
77.8 (SD 24.9) 
82.8 (SD 20.7) 
 
78.4 (SD 29.5) 
88.1 (SD 31.4) 
 
87.5 (SD 15.6) 
84.1 (SD 12.4) 
 
82.7 (SD 16.0) 
84.1 (SD 12.6) 
 
85.7 (SD 19.1) 
80.5 (SD 26.7) 
 
19.7 (SD .5) 
19.8 (SD .9) 
 
1.7 (SD 6.9) 
2.3 (SD 6.2) 
 
11.1 (SD 18.4) 
12.3 (SD 6.2) 
 
12.5 (SD 19.9) 
19.0 (SD 17.8) 
 
76.4 (SD 23.4) 
81.9 (SD 19.6) 
 
81.9 (SD 19.9) 
83.9 (SD 20.9) 
 
81.4 (SD 29.4) 
80.2 (SD 28.0) 
 
82.4 (SD 15.7) 
81.8 (SD 17.1) 
 
85.2 (SD13.0) 
84.3 (SD 18.1) 
 
86.3 (SD 25.8) 
85.4 (SD 26.4) 
 
19.7 (SD .8) 
16.7 (SD .8) 
 
2.9 (SD 6.5) 
2.8 (SD 6.1) 
 
5.8 (SD 26.3) 
4.7 (SD 26.7) 
 
13.7 (SD 20.6) 
13.7 (SD 16.9) 
 
.788 
.866 
 
.536 
.451 
 
.521 
.316 
 
.421 
.071 
 
.582 
.586 
 
.452 
.321 
 
.521 
.564 
 
.423 
.361 
 
.502 
.191 
 
.501 
.491 
 
Insomnia 
Insomnia 3M 
 
Appetite loss 
Appetite loss 3M 
 
Constipation 
Constipation 3M 
 
Diarrhoea 
Diarrhoea 3M 
 
Financial Difficulties 
Financial Difficulties 3M 
 
Urinary symptoms 
Urinary symptoms 3M 
 
Bowel symptoms 
Bowel symptoms 3M 
 
Treatment symptoms 
Treatment symptoms 3M 
 
Sexual activity 
Sexual activity 3M 
 
Sexual function  
Sexual function 3M 
 
6.2 (SD 24.7) 
9.2 (SD 16.2) 
 
7.1 (SD 13.9) 
9.5 (SD 25.1) 
 
15.4 (SD 24.8) 
19.0 (SD 32.5) 
 
9.2 (SD 23.0) 
8.2 (SD 23.1) 
 
2.3 (SD 8.7) 
0 (SD .0) 
 
17.6 (SD 14.6) 
23.6 (SD 9.6) 
 
5.5 (SD 8.7) 
2.8 (SD 4.1) 
 
12.7 (SD 9.9) 
20.8 (SD 9.5) 
 
13.1 (SD 21.9) 
12.5 (SD 15.9) 
 
1.0 (SD .3) 
0 (SD .0) 
 
4.6 (SD 23.9) 
5.6 (SD 20.6) 
 
7.8 (SD 18.6) 
7.8 (SD 18.7) 
 
13.7 (SD 20.6) 
21.6 (SD 28.7) 
 
7.8 (SD 14.6) 
7.6 (SD 14.9) 
 
1.9 (SD 8.0) 
1.9 (SD 8.0) 
 
17.6 (SD 14.6) 
20.4 (SD 13.9) 
 
6.5 (SD 3.7) 
4.1 (SD 7.1) 
 
9.7 (SD 11.6) 
12.1 (SD 10.4) 
 
11.6 (13.7) 
12.5 (SD 18.9) 
 
0.8 (SD .2) 
0 (SD 0) 
 
.224 
.236 
 
.267 
.354 
 
.356 
.451 
 
.267 
.312 
 
.326 
.412 
 
.312 
.545 
 
.599 
.512 
 
.170 
.123 
 
.830 
.631 
 
.859 
.696 
*Scottish Index of Multiple Deprivation (1 most deprived – 5 least deprived)  
 
 
Table 2.  Prevalence of Unmet Supportive Care Needs at 3 Months 
Domains of unmet supportive care needs Low unmet need. I had 
little need for additional 
help. N (%) 
Moderate unmet need. I 
had some need for 
additional help. N (%) 
High unmet need.  I had 
strong need for additional 
help. N (%) 
Pain                                                                                                                                                        (standard) 
                                                                                                                                                           (Intervention) 
2 (8.0%) 
0 (0%) 
4 (16%) 
0 (0%) 
0 (0%) 
0 (0%) 
Lack of energy/tiredness                                                                                                                    (standard) 
                                                                                                                                                          (Intervention) 
5 (20.0%) 
1 (7.7%) 
1 (4.0%) 
0 (0%) 
1 (4.0%) 
0 (0%)  
Feeling unwell a lot of the time                                                                                                        (standard) 
                                                                                                                                                         (intervention) 
1 (4%) 
0 (0%) 
1 (4%) 
0 (0%) 
0 (0%) 
0 (0%) 
Work around home                                                                                                                            (standard) 
                                                                                                                                                         (intervention) 
1 (4%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
Not being able to do the things that you used to do                                                                    (standard) 
                                                                                                                                                          (intervention) 
5 (20%) 
2 (15.4%) 
1 (4%) 
0 (0%) 
0 (0%) 
0 (0%) 
Anxiety                                                                                                                                                   (standard) 
                                                                                                                                                          (intervention) 
3 (12%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
Feeling down or depressed                                                                                                               (standard) 
                                                                                                                                                         (intervention) 
3 (12%) 
2 (15.4%) 
1 (4%) 
0 (0%) 
0 (0%) 
0 (0%) 
Feelings of sadness                                                                                                                              (standard) 
                                                                                                                                                           (intervention) 
3 (12%) 
1 (7.7%) 
0 (0%) 
0 (0%) 
1 (4%) 
0 (0%) 
Fear about the cancer spreading                                                                                                      (standard) 
                                                                                                                                                          (intervention) 
6 (24%) 
1 (7.7%) 
4 (16%) 
0 (0%) 
0 (0%) 
0 (0%) 
Worry that the results of treatment are beyond your control                                                    (standard) 
                                                                                                                                                          (intervention) 
6 (24%) 
1 (7.7%) 
2 (8%) 
0 (0%) 
0 (0%) 
0 (0%) 
Uncertainty about the future                                                                                                            (standard) 
                                                                                                                                                         (intervention) 
9 (36%) 
1 (7.7%) 
0 (0%) 
0 (0%) 
1 (4%) 
0 (0%) 
Learning to feel in control of your situation                                                                                   (standard) 
                                                                                                                                                         (intervention) 
7 (28%) 
1 (7.7%) 
0 (0%) 
0 (0%) 
1 (4%) 
0 (0%) 
Keeping a positive outlook situation                                                                                                (standard) 
                                                                                                                                                          (intervention) 
3 (12%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
Fear about death and dying                                                                                                               (standard) 
                                                                                                                                                         (intervention) 
4 (16%) 
0 (0%) 
1 (4%) 
0 (0%) 
1 (4%) 
0 (0%) 
Changes in sexual feelings                                                                                                                 (standard) 
                                                                                                                                                          (intervention) 
5 (20%) 
1 (7.7%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Changes in sexual relationships                                                                                                        (standard) 
                                                                                                                                                          (intervention) 
5 (20%) 
1 (7.7%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Concerns about the worries of those close to you                                                                        (standard) 
                                                                                                                                                         (intervention) 
5 (20%) 
1 (7.7%) 
2 (8%) 
0 (0%) 
2 (8%) 
0 (0%) 
More choice about which cancer specialist to see                                                                        (standard) 
                                                                                                                                                          (intervention) 
6 (24%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
More choice about which hospital you attend                                                                              (standard) 
                                                                                                                                                          (intervention) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1(4%) 
0 (0%) 
Reassurance by medical staff that the way you feel is normal                                                   (standard) 
                                                                                                                                                         (intervention) 
2 (8%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Hospital staff attending promptly to your physical needs                                                           (standard) 
                                                                                                                                                          (intervention) 
0 (0%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Hospital staff acknowledging, and showing sensitivities  to your emotional needs               (standard) 
                                                                                                                                                          (intervention) 
0 (0%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being given written information about the important aspects of your care needs                (standard) 
                                                                                                                                                          (intervention) 
4 (16%) 
0 (0%) 
3 (12%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being given information (written diagrams, drawings) about managing your illness and side-effects at home                                                                                                                                                                           
                                                                                                                                                                (standard) 
                                                                                                                                                          (intervention) 
6 (24%) 
0 (0%) 
1 (4%) 
0 (0%) 
 
1 (4%) 
0 (0%) 
Being given explanations for those test for which you would like explanations                     (standard) 
                                                                                                                                                         (intervention) 
7 (28%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being adequately informed about the benefits and side-effects of treatment before you choice to have them                                                                                                                                                  
                                                                                                                                                                (standard) 
                                                                                                                                                          (intervention) 
4 (16%) 
0 (0%) 
2 (8%) 
0 (0%) 
 
1 (4%) 
0 (0%) 
Being informed about test results as soon as feasible                                                                  (standard) 
                                                                                                                                                          (intervention) 
3 (12%) 
1 (7.7%) 
5 (20%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being informed about cancer that is under control or diminishing                                            (standard) 
                                                                                                                                                          (intervention) 
5 (20%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being informed about the things that you can do to get well                                                     (standard) 
                                                                                                                                                          (intervention) 
4 (16%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Having access to professional counselling                                                                                      (standard) 
                                                                                                                                                          (intervention) 
3 (12%) 
0 (0%) 
1 (4%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being given information about sexual relationships                                                                     (standard) 
                                                                                                                                                          (intervention) 
3 (12%) 
0 (0%) 
1 (4%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being treated like a person not just another case                                                                         (standard) 
                                                                                                                                                          (intervention) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
1 (4%) 
0 (0%) 
Being treated in a hospital or clinic that is physically pleasant as possible case                      (standard) 
                                                                                                                                                          (intervention) 
0 (0%) 
0 (0%) 
2 (8%) 
0 (0%) 
1 (4%) 
0 (0%) 
Having one member of hospital staff with whom you can talk to                                              (standard) 
                                                                                                                                                          (intervention) 
5 (20%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (8%) 
0 (0%) 
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What is the prostate? 
Only men have a prostate gland. The prostate is usually the size and 
shape of a walnut and naturally grows bigger as you get older.  The 
normal size of a prostate is around 40g.  It sits underneath the bladder 
and surrounds the urethra – the tube men urinate and ejaculate 
through. 
It’s main job is to help make semen – the fluid that carries sperm. 
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Facts and figures 
Below are some of the very basic facts and figures about prostate 
cancer. 
Across the UK 
 Prostate cancer is the most common cancer in men. 
 Over 47,000 men are diagnosed with prostate cancer every 
year – that's 130 men every day. 
 Every hour one man dies from prostate cancer – that's more 
than 10,800 men every year. 
 1 in 8 men will get prostate cancer in their lifetime. 
 Over 330,000 men are living with and after prostate cancer. 
In Scotland 
 More than 3,000 men are diagnosed with prostate cancer 
every year in Scotland. 
 More than 850 men die from prostate cancer every year in 
Scotland. 
In England 
 Almost 40,000 men are diagnosed with prostate cancer every 
year in England. 
 More than 9,500 men die from prostate cancer every year in 
England. 
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In Wales 
 More than 2,500 men are diagnosed with prostate cancer 
every year in Wales. 
 More than 600 men die every year from prostate cancer in 
Wales. 
In Northern Ireland 
 More than 1,000 men are diagnosed with prostate cancer 
every year in Northern Ireland. 
 More than 250 men die every year from prostate cancer in 
Northern Ireland. 
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How can I help myself? 
Everyone has their own way of dealing with prostate cancer, but you 
may find some of the following suggestions helpful. 
 
Look into your treatment options 
Find out about the different types of treatment available to you. Bring 
a list of questions to your doctor or nurse. And ask about any side 
effects so you know what to expect and how to manage them. This 
will help you decide what’s right for you. 
 
“Remember, your Prostate Cancer Care Team are here to help and 
support you.”  
 
Talk to someone 
Unload what’s going on in your head – find someone you can talk to. 
It could be someone close, or someone trained to listen, like a 
counsellor or your medical team. Your GP, nurse or other health 
professionals involved in your care should be able to answer any 
questions or concerns you might have. 
 
Set yourself some goals 
Set yourself goals and things to look forward to – even if they’re just 
for the next few weeks or months.  It might be doing more exercise, 
gardening or getting ready for a holiday. 
 
Look after yourself 
Take time out to look after yourself. When you feel up to it, learn 
some techniques to manage stress and to relax – like listening to 
music or breathing exercises. 
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Eat a healthy, balanced diet 
Eating well is good for your general health and lowers your risk of 
other health problems. There is also some evidence that certain foods 
may slow down the growth of prostate cancer or lower the risk of it 
coming back after treatment. 
 
Be as active as you can 
Keeping active can improve your physical strength and fitness, and 
can lift your mood. Research shows that physical activity can help to 
slow down the growth of prostate cancer. It can also help you stay a 
healthy weight, which may be important for lowering your risk of 
advanced prostate cancer. Even if you don’t feel able to do a lot of 
physical activity, a small amount will still help – take things at your 
own pace and don’t overdo it. 
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Who can help? 
 
Your Specialist Prostate Cancer Nurses 
Your Specialist Nurses can answer your questions and explain your 
diagnosis and treatment options. They’ve got time to listen to any 
concerns you or those close to you have in confidence. 
 
Prostate Cancer Specialist Nurse Team, Ninewells Hospital: 
01382 660111, extension 35138. 
 
Your medical team 
It could be useful to speak to your nurse, doctor, GP or anyone in your 
medical team. They can explain your diagnosis, treatment and side 
effects, listen to your concerns, and put you in touch with others who 
can help. 
 
Trained counsellors 
Counsellors are trained to listen and can help you to find your own 
ways to deal with things. Many hospitals have counsellors or 
psychologists who specialise in helping people with cancer.  Your GP 
may also be able to refer you to a counsellor, or you can see a private 
counsellor. To find out more, contact the British association for 
Counselling & Psychotherapy. 
 
http://www.bacp.co.uk/ 
 
Local support groups 
You have local support groups both in Dundee and Perth, where 
men get together to share their experiences – you can ask questions, 
offload worries and know that someone understands what you’re 
going through. Some groups have been set up by local health 
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professionals, others by men themselves. Many also welcome 
partners, friends and relatives. 
 
Online community 
Prostate Cancer UK online community is a place where you can talk 
about whatever's on your mind – your questions, your ups and your 
downs. Anyone can ask a question or share an experience. It’s a place 
to deal with prostate cancer together. 
 
http://community.prostatecanceruk.org/ 
Spiritual support 
You might begin to think more about spiritual beliefs as a result of 
having prostate cancer. It’s important that you get spiritual support if 
you need it. This could be from your friends or family, or from your 
religious leader or faith community. 
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 Lifestyle and Nutrition 
 
Studies have shown that lifestyle — especially nutrition and exercise 
— has a significant influence in prostate cancer prevention and 
treatment.  
Treatment options for prostate cancer are more effective than ever 
before. Yet, for many men, the diagnosis and treatment of cancer 
brings to their attention the need to change their diet and exercise 
behaviors. Men are beginning to realise that a healthy diet and 
regular exercise can be an important step toward preventing other 
diseases that commonly occur with aging, including heart disease and 
diabetes. 
Exciting new data suggest that this same approach may also slow 
prostate cancer growth.    
 
You may have had prostate cancer, but now you are in charge of your 
life, adopting new healthy habits and enjoying each day to its fullest. 
As a prostate cancer thriver, you can use the latest knowledge about 
nutrition and exercise to improve your overall health and quality of 
life. Your diagnosis of prostate cancer can be the beginning of a 
healthier lifestyle. 
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Implementing a Plan for Success 
 
It is critical to focus on the benefits of a healthy diet and regular 
exercise.    We describe how a healthy diet and regular physical 
activity may help you manage the effects of prostate cancer and its 
treatment. 
 
1 Making a commitment to change is a first step in successful 
thrivership 
2 Effective change can only be accomplished in steps 
3 Learn from mistakes made over time and use the gains to move 
forward 
4 Reduce stress: live a balanced life and take care of yourself 
5 Control your environment: plan ahead to eat healthy and minimize 
stress 
6 Monitor your action: track your behaviours to help chart your 
progress 
7 Establish a support system: maintain healthy relationships with 
people who understand what you are going through 
 
We don’t recommend any set diet or exercise programme. Instead, 
we suggest ways to improve your overall health, including some 
changes that might help with your prostate cancer. 
Key Points to Remember 
1 Lose body fat: eat fewer calories per day than you burn 
2 Maintain muscle mass: increase protein intake and exercise 
3 Exercise every day: combine cardio-fitness and weight lifting 
4 Eat fruits and vegetables: recommended nine servings a day 
 
Key Points to Remember 
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Building Strong Muscles 
Increased protein intake at the upper end of the range recommended 
by the Institute of Medicine (10% to 35% of total calories) has been 
shown, in several clinical studies, to reduce hunger and improve lean 
body mass during weight loss. Exercising for durations of 
approximately one hour each day is an excellent strategy for weight 
maintenance, while progressive resistance training has been shown 
to build muscle, increase resting metabolism, improve glucose 
tolerance, increase strength, muscle function, and aerobic fitness, 
contribute to increased bone density, and improve quality of life. 
 
Note also that maintaining muscle mass can have a positive impact 
on metabolism. A pound of muscle burns 14 calories for every 3 
calories burned by a pound of fat. Thus, the number of calories 
burned per day is at least in part determined by the ratio of muscle 
to fat. 
 
Avoiding the muscle loss common in aging, inactivity, and hormonal 
therapies and/or gaining muscle through increased protein intake 
and exercise can help you achieve and maintain a healthy body 
weight, giving you more energy and an ability to enjoy active sports 
more fully. 
 
Restoring a Healthful Caloric Balance 
Concentrating on fruits and vegetables can pay dividends 
immediately. The average vegetable serving is only 50 calories and 
the average fruit serving is only 70 calories, while the average serving 
of refined carbohydrates such as potatoes, rice, pasta, bread, bagels, 
or cakes is more than 200 calories. Considering that you have to run 
3 miles in 30 minutes to burn off the calories in a medium potato and 
bicycle 8 miles in 30 minutes to burn off the calories in a donut, 
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minimizing your caloric intake from these types of refined 
carbohydrates can help you maximize the effects of regular exercise. 
 
 
1 Avoiding muscle loss and/or gaining muscle through increased 
protein intake and exercise can help in achieving and maintaining a 
healthy body weight. 
2 Increase intake of fruits and vegetables and minimize caloric 
intake from refined carbohydrates. 
 
Adopting a Healthy Approach 
It is a lot easier than you think to incorporate good nutrition and 
exercise into your everyday routine. 
 
The key is to recognise that implementing dietary changes does not 
mean giving up things you love and that exercising does not mean 
spending additional time that you don’t have. The key is to see your 
life in a new way — with a new set of lifestyle changes all designed to 
turn you from a prostate cancer survivor into a prostate cancer 
thriver. 
 
Lose the body fat 
Losing fat is a simple equation: eat fewer calories per day than you 
burn and increase your activity levels. This can be done by changing 
your dietary pattern away from high fat foods, sweets, fast foods, and 
savory snacks and eating more fruits and vegetables, low-fat proteins 
from poultry, fish, and seafood, and fewer refined carbohydrates.  
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Here are some practical examples of places you can cut calories: 
 
• replace high-fat red meats for fish and white meat (turkey or 
chicken)  
• replace rice, pasta, potato, and breads for fruits and vegetables  
• replace ice creams, cakes, pastries for mixed berries and fruits  
• replace  cheese and full-fat dairy products for low-fat dairy and soy 
products  
• replace soft drinks for water. 
 
Maintain muscle mass 
In order to maintain muscle mass as you age, it is important to take 
in adequate amounts of protein and to exercise muscles adequately 
to maintain them. As you age, the body’s metabolism slows down due 
in large part to the decrease in muscle mass that is seen with 
inactivity. It is harder to build muscle as you age and it breaks down 
more quickly with inactivity than in younger individuals. However, it 
is possible to build and maintain muscle mass well into your 90s by 
simply eating adequate protein and doing muscle building exercises. 
 
Also, building muscle mass is one of the most effective ways to 
change your metabolism: build 10 extra pounds of muscle, and you 
will burn an extra 140 calories per day. However, to maintain that 
muscle you need to do more than simply provide the extra 140 
calories per 10 pounds; you must also supply the right amount of the 
right kinds of protein to nourish the muscles. 
 
Your lean body mass determines how much protein you need each 
day. In fact, it’s about twice what was recommended by government 
advisory groups until recently, when the Institute of Medicine 
broadened its recommendation to 10% to 35% of calorie intake. It 
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takes about 1 gram of protein per pound of lean body mass or 29% of 
resting energy expenditure, which is the number of calories you burn 
at rest to build and maintain muscle.  
 
For example, a typical man with 150 pounds of lean body mass will 
burn 2100 calories at rest per day and will need about 150 grams of 
protein per day. 
 
Here is a list of some low-fat, high protein choices you can make: 
 
• 7 egg whites: 25 g protein and 115 calories 
• Chicken breast (4 oz): 25 g protein and 140 
calories 
• Ocean-caught fish (4 oz): 25 g protein and 140 
calories 
• Canned tuna in water ((3.5 oz): 25 g protein and 
110 calories 
 
Exercise every day 
Regular exercise will help you lose fat, build muscle, and improve your 
outlook overall.  22A combination of cardio-fitness and weight lifting 
will not only help to round out the benefits, but the variety will help 
make it more interesting. This is key to sticking to a regular routine.   
Choose an exercise you like and/or one that you can do with friends 
to make it more enjoyable. For example, walk 30 minutes every day 
at a comfortable pace and lift weights three times each week, 
alternating different body parts and allowing a day of rest between 
weight-lifting days.  
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If you work on your chest muscles and triceps one day, switch to your 
back muscles and biceps on the next, followed by leg muscles and 
shoulders on the third day. 
 
Most important, obtain professional instruction on how to perform 
exercises for each of these muscle groups and consult with your 
doctor before starting the exercise program to be sure it is safe for 
you. A certified fitness instructor, exercise physiologist, or physical 
therapist can provide exercise instruction and ensure that you are 
maximizing the benefit from your workouts. 
 
Ask you Nurse/Doctor to refer MOVE MORE Program, to enable you 
to have your own personalised programme. 
 
                                                   
 
Eat fruits and vegetables 
We recommend eating 9 servings of fruits and vegetables every day, 
equivalent to about one cup or 100 grams per serving. Why is this 
important? A typical serving of vegetables has about 50 calories and 
a typical serving of fruit has about 70 calories, making them some of 
the least calorie-dense food ounce per ounce. So by simply increasing 
the amount of fruits and vegetables you eat each day, you will be 
decreasing the number of calories per bite of food even while packing 
in high levels of nutrients.   Also, fruits and vegetables are rich in fibre, 
so five servings of fruit and vegetables can easily get you to the 
recommended 25 grams of fibre per day.to Re 
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Why is a healthy lifestyle important? 
 
A healthy lifestyle can give you more control over your health and 
help you to improve it. Lots of things can affect your health, including: 
• body weight 
• diet 
• physical activity 
• alcohol 
• smoking. 
 
Alcohol 
We don’t know if alcohol has any specific effect on men with prostate 
cancer. But we do know that drinking too much alcohol can make you 
put on weight and causes health problems such as heart disease and 
some other cancers. The government suggests that men should not 
regularly drink more than three to four units of alcohol a day. 
 
How many units of alcohol are in a drink? 
• A pint of lager, beer or cider contains 2-3 units. 
• A 175ml glass of wine contains about 2 units. 
• A 25ml measure of 40 per cent single spirit with mixer contains 1 
unit. 
 
If you have urinary problems after treatment, try to drink less alcohol. 
Alcohol can irritate the bladder and make urinary problems worse.  
 
Smoking 
Smoking increases the risk of health problems such as heart disease, 
stroke and some other cancers. It may also be harmful for men with 
prostate cancer. Some studies suggest that smoking may increase the 
chance that prostate cancer will grow and spread to other parts of 
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the body (advanced prostate cancer). The more you smoke, the 
greater the risk. But if you stop smoking, your risk should start to drop 
– and after 10 years it could be as low as men who have never 
smoked. 
 
Stopping smoking can also help to reduce the side effects of 
treatment for prostate cancer. For example, you may be less likely to 
get certain urinary problems after radiotherapy if you don’t smoke. 
Smoking also increases your risk of bone thinning. If you’re having 
hormone therapy for your prostate cancer you’re already at risk of 
bone thinning, but stopping smoking will help reduce your overall 
risk. 
 
                            
 
Speak to your healthcare team about Smoking Cessation service. 
 
Heart disease and diabetes 
Hormone therapy may increase your risk of heart disease and 
diabetes. A healthy lifestyle, including a healthy diet and regular 
physical activity, can help reduce your risk of heart disease and 
diabetes. 
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Bone thinning 
Long-term hormone therapy can cause your bones to gradually get 
thinner and weaker. Severe bone thinning can lead to a condition 
called osteoporosis, which increases your risk of broken bones 
(fractures). A number of lifestyle changes may help to reduce your 
risk of bone thinning. 
 
Calcium and vitamin D are important for strong bones. You can get 
vitamin D from eating oily fish, such as salmon, mackerel and 
sardines, or foods with added vitamin D. But most of your vitamin D 
is made inside the body when your skin is exposed to sunlight. You 
may need to take calcium and vitamin D supplements to help reduce 
your risk of bone thinning. 
 
Drinking lots of alcohol can increase your risk of osteoporosis, so try 
not to drink more than the recommended amount. Smoking can also 
increase the risk of bone thinning.  
 
                                           
 
Hot flushes 
Hot flushes are a common side effect of hormone therapy. Staying a 
healthy weight may help you manage hot flushes. Try to cut down on 
spicy foods, alcohol and drinks that contain caffeine, such as tea and 
coffee. Some men use herbal remedies, such as sage tea or 
supplements containing black cohosh, to help manage their hot 
flushes. But there is no scientific evidence that these are effective and 
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some, including black cohosh, may be harmful. Speak to your doctor 
before taking any herbal remedies. 
 
Extreme tiredness (fatigue) 
Some treatments for prostate cancer, including hormone therapy, 
radiotherapy and chemotherapy, can cause extreme tiredness.  Light 
to moderate exercise, such as walking or swimming, can make you 
feel more awake. And doing this type of exercise along with strength 
training, such as lifting light weights, may be even more effective. 
If your treatment is making you feel tired, you may find it difficult to 
be active. Try to plan activities at times when you usually have more 
energy. If you feel particularly tired, just do gentle exercise for a short 
time and take lots of breaks. You can even exercise from your chair or 
bed – for example, use a resistance band to help you lift and stretch 
your arms and legs.   
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How will prostate cancer affect my sex life? 
Prostate cancer can affect your sex life in three overlapping ways - 
your mind, body and relationships. Finding out you have cancer can 
make you feel down or anxious, changing your feelings about sex. 
Treatment can damage the nerves and blood supply needed for 
erections. Hormone therapy can affect your desire for sex. Coping 
with cancer can change your close relationships, or your thoughts 
about starting one. 
               
Some common worries 
 You can’t pass on cancer through sexual activity. 
 Having sex will not affect your cancer or the success of your 
treatment. 
 Having sex has no effect on the chances of your cancer 
coming back. 
 Erections are still safe even if you have a catheter in. 
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What causes erection problems? 
When you're sexually aroused your brain sends signals to the nerves 
in your penis. The nerves increase the blood flow to your penis, 
making it stiff and giving you an erection. Anything that interferes 
with your nerves, blood supply or your sexual desire (libido) can make 
it difficult to get or keep an erection. You may hear this called erectile 
dysfunction or impotence.  Many men get problems with their 
erections and this is more likely to happen as men get older. 
 
Treatments for prostate cancer 
Some treatments for prostate cancer can damage the nerves and 
blood vessels that are needed for an erection. Treatments that can 
have this effect include surgery, external beam radiotherapy, 
brachytherapy, high intensity focused ultrasound and cryotherapy. 
All types of hormone therapy can cause erection problems. Having 
less interest in sex can also play a part. 
Treatments for erection problems 
Many of the treatments for erection problems work by improving the 
flow of blood to the penis. There are a number of treatments 
available. 
 
Tablets 
A group of drugs called phosphodiesterase type 5 (PDE5) inhibitors 
can help men get erections. These include: 
 sildenafil (generic sildenafil or Viagra®) 
 tadalafil (Cialis®) 
 vardenafil (Levitra®) 
 avanafil (Spedra®) 
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PDE5 tablets don’t cause spontaneous erections - they only work if 
you are sexually aroused. They normally take 30 minutes to an hour 
before they start to work. 
Sildenafil, vardenafil and avanafil are taken when needed and will 
work for four to six hours. This means you’ll be able to get an erection 
if you’re sexually aroused in that time. 
Tadalafil can work for up to 36 hours, so it allows you to have more 
spontaneous sexual activity. Your doctor may suggest you take a low-
dose tablet (5mg) every day. 
Don’t take PDE5 tablets with nitrates: Nitrates are usually used to 
treat heart problems and are used in some recreational drugs (called 
poppers). If you have a heart problem or you’re taking nitrates discuss 
other ways to treat your erection problems with your doctor or 
specialist. 
 
Injections 
Erection problems can also be treated with a drug called alprostadil 
(Caverject® or Viridal Duo®) injected into the side of your penis. An 
injection may sound alarming but many men find it isn’t that bad and 
doesn’t hurt. The first time you use the drug a nurse or doctor in the 
clinic will show you how to inject into your penis with a very fine 
needle. 
 
The drug causes the penis to fill with blood and you’ll get an erection 
within 5 to 10 minutes. The erection will normally last for 30 to 40 
minutes. 
 
 
 
24 
 
Pellets or cream 
The drug alprostadil is also available as a small pellet, called MUSE®, 
and as a cream called Vitaros®.  These may not work as well as the 
injections but are a good alternative if you don’t like the idea of an 
injection.   You use an applicator to insert the pellet into the opening 
or ‘eye’ of the penis.  
 
You or your partner can then massage your penis to help absorb the 
drug. You’ll get an erection within 5 to 10 minutes, which will last 
between 30 and 60 minutes.   
 
The cream may take a little longer to work. The cream is put onto the 
tip and ‘eye’ of the penis and gently rubbed in. 
 
Vacuum pump 
You use a pump and a plastic cylinder to create a vacuum, which 
makes blood flow into your penis to make it hard. You then slip a 
constriction ring from the end of the cylinder onto the base of your 
penis. This stops most of the blood escaping when you remove the 
vacuum pump. You shouldn't wear the ring for longer than 30 
minutes at a time. 
 
The vacuum pump may help men get an erection hard enough for 
penetration. It may also help maintain the length and thickness of the 
penis if used daily within four to eight weeks after surgery. 
 
Implant 
You have an operation to put an implant inside your penis. Implants 
are usually only recommended if other treatments haven’t worked. 
There are two main types: 
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 Semi-rigid rods that keep your penis fairly firm all the time 
but allow it to be bent down when you don’t want an 
erection. 
 An inflatable implant in your penis and a pump in your 
scrotum. When you squeeze the pump the implant fills with 
fluid (saline) to make the penis hard. Your erection will last 
for as long as the implant is inflated. 
 
 
Sex therapy 
Because getting an erection also relies on your thoughts and feelings, 
tackling any worries or relationship issues as well as having medical 
treatment for erection problems, often works well. 
Getting treatment and support 
Speak to your GP or doctor or nurse at the hospital. Men with 
prostate cancer can get free medical treatment for erection problems 
or other sexual problems on the NHS. Your GP or doctor or nurse at 
the hospital can prescribe treatment if you want help getting 
erections for masturbation or sex.  
 
Talking about sex 
It can be tricky talking about sex, but talking to your doctor or nurse 
will mean you can get treatment and support. It can also help you feel 
better and more in control. 
Changes in penis size 
Some men find that their penis is shorter after surgery (radical 
prostatectomy). This happens because of changes to the tissue inside 
the penis. Other treatment such as hormone therapy with 
radiotherapy may also cause changes to the size of your penis. 
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Encouraging blood flow to the penis after surgery may improve 
erections and prevent your penis becoming smaller. In particular, 
using a vacuum pump on its own or with PDE5 tablets may help 
maintain your penis size and improve erections. 
Changes to orgasm and ejaculation 
After prostate cancer treatment you will still have feeling in your 
penis and you should still be able to have an orgasm, but this may feel 
different from before. 
After surgery you will no longer ejaculate when you orgasm, as the 
prostate and seminal vesicles, which make some of the fluid in the 
semen, are removed during the operation. Instead you may have a 
'dry orgasm' where you feel the sensation of orgasm but don't 
ejaculate any semen. Occasionally, you might release a small amount 
of liquid from the tip of your penis during orgasm, which may be fluid 
from glands lining the urethra. 
If you've had other treatments, you may produce less semen during 
and after treatment. Some men on hormone therapy say their 
orgasms feel less intense. 
If you've had surgery for an enlarged prostate called a called TURP 
(transurethral resection of the prostate) or radiotherapy you may get 
retrograde ejaculation. This is when you orgasm and the semen 
doesn't come out straightaway, but is passed out of the body when 
you next urinate. It isn't harmful and shouldn't affect your enjoyment 
of sex but it may feel quite different to the orgasms you're used to. 
Some men leak urine when they orgasm, or feel pain. Others find they 
don't last as long during sex and reach orgasm quite quickly. 
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Your thoughts and feelings 
If your ability to get erections and your experience of sex have 
changed then this can have a big impact on you. You may feel worried, 
unsatisfied, angry and as if you've lost a part of yourself. But there are 
ways to tackle these issues and find solutions that work for you (see 
the section on help). 
Some couples find it useful to see a relationship counsellor. Help is 
available through Relate: 
https://www.relate.org.uk/ 
Sex therapy is available on the NHS or privately. 
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Sex when you're single 
Being sexually active and feeling attractive can be just as important if 
you are a single man. All the treatments described here are available 
to you if you're single - whether you want to be able to masturbate, 
have sex, or want to start a new relationship. 
Some men worry that having problems with erections will affect their 
chances of having a new relationship. Fear of rejection is natural, and 
everyone has their own hang-ups whether they have had cancer or 
not. If you're single, you may want time to come to terms with any 
changes prostate cancer has caused for you, before you start having 
sex or dating. 
 
Try talking over your worries with someone you feel comfortable 
with, such as a friend. Counselling or sex therapy may also help if you 
would prefer to talk to someone you don't know. 
            
 
 
 
 
 
 
29 
 
 What can I do to help myself if I have urinary 
symptoms? 
 
Sometimes men can experience the following symptoms, before, 
during or after treatment, including: 
 bladder irritation 
 needing to urinate more often (urinary frequency) 
 a sudden urge to urinate (urinary urgency) 
 difficulty urinating 
 Some men can also leak urine 
 
Lifestyle changes 
Urinary problems can affect your self-esteem and independence, as 
well as your work, social and sex life. 
Making some changes to your lifestyle can help, and there are some 
practical steps that can make things easier. 
 Try to drink plenty of fluids, but cut down on fizzy drinks, 
alcohol, tea and coffee as these may irritate the bladder 
 Do regular pelvic floor muscle exercises can help strengthen 
the muscles that control when you urinate. 
 Try to stay a healthy weight. Being overweight can put 
pressure on your bladder and pelvic floor muscles. 
 If you smoke, try to stop. Smoking can cause coughing which 
puts pressure on your pelvic floor muscles. See smoking 
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cessation service for more information about stopping 
smoking 
 Plan ahead when you go out. For example, find out where 
there are public toilets before leaving home. 
 Pack a bag with extra pads, underwear and wet wipes. Some 
men also find it useful to carry a screw-top container in case 
they can’t find a toilet. 
                                             
 Get an Urgent Toliet Card to help make it easier to ask for 
urgent access to a toilet. 
 Disability Rights UK runs a National Key Scheme for anyone 
who needs access to locked public toilets across the UK 
because of a disability or health condition. 
 If you often need to use the toilet at night, leave a light on in 
case you’re in a hurry, or keep a container near your bed. 
 Drink plenty of fluids (1.5-2 litres, or 3-4 pints a day), but try 
to avoid fizzy drinks, drinks containing caffeine – such as tea, 
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coffee and cola – and alcohol, as these can irritate the 
bladder. 
 Some men find that drinking cranberry juice helps. But you 
should avoid cranberry juice if you’re taking warfarin to thin 
your blood. 
 Drugs called anti-cholinergics can help to reduce frequency, 
urgency and leaks. 
 You may also need to urinate more often at night (nocturia). 
If this happens, it might help to drink less in the two hours 
before you go to bed. 
 
 
Urine retention 
Some men can still urinate a little, but can’t empty their bladder fully 
– this is known as urine retention. The first signs often include: 
 leaking urine at night 
 feeling that your abdomen (stomach area) is swollen 
 feeling that you’re not emptying your bladder fully 
 a weak flow when you urinate. 
Tell your doctor or nurse if you get any of these symptoms. Urine 
retention is usually painless, but the pressure of the urine can cause 
the bladder muscles to slowly stretch and become weaker. 
Treatments for chronic urine retention include:  a catheter to drain 
urine from the bladder, drugs (alpha blockers or 5-alpha-reductase 
inhibitors), surgery to widen the urethra or the opening of the 
bladder. 
32 
 
What can I do to help myself if I have bowel 
symptoms? 
 
Some prostate cancer treatments can cause bowel symptoms in men 
(in particular radiotherapy).  Such symptoms can include: 
 loose and watery bowel movements (diarrhoea) 
 passing more wind than usual 
 needing to go to the toilet more often, or having to rush to 
the toilet 
 feeling an urge to have a bowel movement, but then not 
being able to go 
 a feeling that your bowels haven’t emptied properly 
 pain in the stomach area (abdomen) or back passage bleeding 
from the back passage – this is rare. 
If you are experiencing new bowel symptoms it is important for you 
to tell your doctor or nurse.  There are a number of practical life styles 
changes that can help if you are experiencing bowel symptoms: 
 Drink plenty of liquid up to 1.5 to 2 litres a day to replace lost 
fluid.   
 Avoid coffee and citrus fruits (if you have loose stool) 
 Skin care at back passage: use unscented baby wipes instead 
of toilet paper to wipe yourself after you’ve been to the toilet, 
advice to have a warm bath to help soothe pain and help with 
healing, pat the area dry with a soft towel after a shower or 
bath – don’t rub.  
 Applying Vaseline around the back passage can help.  
 Avoid wearing tight trousers or underwear. Cotton 
underwear will help to keep the area ventilated.  
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 Advice on gentle exercise (if able, brisk walking for at least 30 
minutes, three times per week), is conducive to a more 
normal bowel routine. 
 Eat food rich in fibre such as: fruit, vegetables, nuts, seeds, 
pulses, and wholemeal bread (to avoid constipation). 
How will hormone therapy affect me? 
Hot flushes are a common side effect of hormone therapy. They can 
be similar to the hot flushes women get when they're going through 
the menopause. They may happen suddenly without warning or they 
may be triggered by stress, a hot drink or a change in the temperature 
around you. 
Hot flushes can vary from a few seconds of feeling overheated to a 
few hours of sweating that can stop you from sleeping or cause 
discomfort. Some men may not be worried by them, but others find 
them very disruptive and difficult to deal with. If your hot flushes are 
affecting your everyday life, speak to your doctor or nurse. 
Breast swelling and tenderness 
Hormone therapy may cause swelling (gynaecomastia) and 
tenderness in the chest area. The amount of swelling can vary from a 
small amount of swelling to a more noticeably enlarged breast. 
Tenderness can affect one or both sides of the chest and can range 
from mild sensitivity to ongoing pain. 
Breast swelling and tenderness are more common if you take anti-
androgen tablets such as bicalutamide on their own. If you take 
oestrogen tablets, you may also get breast swelling. 
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Breast swelling and tenderness can make some men feel 
uncomfortable or embarrassed about their bodies. But there are 
treatments available which can help prevent or reduce these side 
effects.  
These include: 
 treating the breast area with a single dose of radiotherapy 
 tablets called tamoxifen 
 surgery to remove some of the breast tissue. 
 
Risk of heart disease and diabetes 
Hormone therapy may increase your risk of heart disease and 
diabetes.  You may be able to help reduce your risk by: 
 eating a healthy diet 
 being physically active 
 limiting the amount of salt you eat 
 avoiding smoking 
 cutting down on alcohol. 
 
Memory and Concentration 
Testosterone may be linked to men's memory and concentration. 
Some studies have suggested that hormone therapy could affect this. 
But we don't know for sure whether any changes are caused by the 
hormone therapy or by something else. For example, feeling tired, 
stressed or anxious can all affect your memory or ability to 
concentrate. And these problems can happen as you get older. 
Whatever the cause, you may find problems with memory or 
concentration very frustrating. There are things you can do which 
might help. 
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Further support and information 
 
 
Prostate Cancer Specialist Nurses 
NHS Tayside 
Ninewells 
Dundee 
Telephone: 01382 660111, Extension 35138 
 
Prostate Cancer UK 
http://prostatecanceruk.org/get-support/our-specialist-nurses 
Support Nurses 
Telephone: 0800 074 8383 
 
Healthy Working Lives, Fit for Work 
Support for returning to work after Cancer (including self-employed 
advice) 
Telephone: 0800 019 2211 
 
Move More Programme (Macmillan Cancer Support) 
Macmillan Development Office 
Telephone: 01382 432407 
 
Macmillan Cancer Support 
www.macmillan.org.uk 
Telephone: 0808 808 0000 
 
Sexual Advice Association 
www.sda.uk.net 
Telephone: 020 7486 7262 
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QUIT (support to stop smoking) 
www.quit.org.uk 
Telephone: 0800 00 22 00 
 
Mind (information to support psychological well-being, issue such 
as anxiety or depression) 
www.mind.org.uk 
Telephone:  0300 123 3393 
 
Relate (information, advice on relationships and sex therapy) 
www.relate.org.uk 
Telephone: 0300 100 1234 
 
Samaritans (non-judgemental emotional support 24 hours per day) 
www.samaritans.org.uk 
Helpline: 0845 790 9090 
 
Maggie’s Centre Dundee 
https://www.maggiescentres.org/our-centres/maggies-dundee/ 
Telephone: 01382 632999 
 
NHS 24 
www.nhs24.com 
Telephone: 08454 242424 
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